These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3307401)

  • 21. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
    Ghaffari S; Kazemi B; Golzari IG
    Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of intracoronary and intravenous methods of thrombolytic streptokinase therapy of patients with myocardial infarct].
    Markov VA; Varvarenko VI; Kun VI; Krylov AL; Stoliarov VA
    Kardiologiia; 1988 May; 28(5):20-3. PubMed ID: 3411854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke in patients treated with thrombolytic therapy for acute myocardial infarction. The thrombosis in myocardial infarction clinical trial and a review of placebo-controlled trials.
    Price TR
    Stroke; 1990 Nov; 21(11 Suppl):III8-9. PubMed ID: 2122557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarction.
    Res JC; Simoons ML; van der Wall EE; van Eenige MJ; Vermeer F; Verheugt FW; Wijns W; Braat S; Remme WJ; Serruys PW
    Br Heart J; 1986 Nov; 56(5):414-21. PubMed ID: 3539162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.
    Zijlstra F; de Boer MJ; Beukema WP; Liem AL; Reiffers S; Huysmans D; Hoorntje JC; Suryapranata H; Simoons ML
    Eur Heart J; 1996 Mar; 17(3):382-7. PubMed ID: 8737211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous streptokinase in acute evolving myocardial infarction--six to thirty-six months follow up.
    Chopra KL; Chopra HK; Aggarwal KK
    Indian Heart J; 1990; 42(1):13-25. PubMed ID: 2190912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular pharmacology (XIII). The efficacy of different thrombolytic drugs in the treatment of acute myocardial infarct].
    López-Sendón J; López de Sá E; Bobadilla JF; Rubio R; Bermejo J; Delcán JL
    Rev Esp Cardiol; 1995 Jun; 48(6):407-39. PubMed ID: 9324694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.
    Vermeer F; Simoons ML; de Zwaan C; van Es GA; Verheugt FW; van der Laarse A; van Hoogenhuyze DC; Azar AJ; van Dalen FJ; Lubsen J
    Br Heart J; 1988 May; 59(5):527-34. PubMed ID: 3132962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial.
    Khaja F; Walton JA; Brymer JF; Lo E; Osterberger L; O'Neill WW; Colfer HT; Weiss R; Lee T; Kurian T; Goldberg AD; Pitt B; Goldstein S
    N Engl J Med; 1983 Jun; 308(22):1305-11. PubMed ID: 6341842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
    French JK; Edmond JJ; Gao W; White HD; Eikelboom JW
    Am J Cardiovasc Drugs; 2004; 4(2):107-15. PubMed ID: 15049722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolytic therapy: a review of its use in acute myocardial infarction.
    Bizjak ED; Mauro VF
    Ann Pharmacother; 1998; 32(7-8):769-84. PubMed ID: 9681094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myocardial revascularization in the developing phase of myocardial infarction using intracoronary thrombolytic therapy].
    Puel J; Miquel JP; Massabuau P; Cassagneau B; Miluau S; Fauvel JM; Bounnoure JP
    Rev Med Univ Navarra; 1984 Dec; 28(4):43-6. PubMed ID: 6528151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.
    Goa KL; Henwood JM; Stolz JF; Langley MS; Clissold SP
    Drugs; 1990 May; 39(5):693-719. PubMed ID: 2191849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complex.
    Takens BH; Brügemann J; van der Meer J; den Heijer P; Lie KI
    Am J Cardiol; 1990 Jun; 65(22):1422-4. PubMed ID: 2191581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of myocardial perfusion after thrombolysis assessed by thallium-201 exercise scintigraphy. Report of the Working Group on Thrombolytic Therapy in Acute Myocardial Infarction of the Netherlands Interuniversity Institute of Cardiology.
    van der Wall EE; Res JC; van den Pol R; Vermeer F; van der Laarse A; Braat S; Fioretti P; Krauss XH; Verheugt FW; Simoons ML
    Eur Heart J; 1988 Aug; 9(8):828-35. PubMed ID: 2972542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of U.S. clinical trials program for evaluation of anistreplase.
    Anderson JL
    Clin Cardiol; 1990 Mar; Suppl 5():V33-8; discussion V67-72. PubMed ID: 2182239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction.
    Erbel R; Pop T; Meinertz T; Olshausen KV; Treese N; Henrichs KJ; Schuster CJ; Rupprecht HJ; Schlürmann W; Meyer J
    Am Heart J; 1988 Mar; 115(3):529-38. PubMed ID: 3278574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolytic intervention and its effect on mortality in acute myocardial infarction: review of clinical trials.
    Brooks-Brunn JA
    Heart Lung; 1988 Nov; 17(6 Pt 2):756-61. PubMed ID: 3142823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.